Laser Assisted Delivery of Minoxidil in Androgenetic Alopecia
Not yet recruiting
University of Minnesota - Clinical and Translational Science Institute
The objective of this study is to evaluate the safety and efficacy of fractionated ablative
10,600nm CO2 laser assisted delivery of 2% minoxidil solution in the treatment of MPHL. In
this cohort study, patients will randomly be assigned stand-alone laser treatment, laser
assisted drug delivery of minoxidil 2% solution, and laser assisted drug delivery of
minoxidil 2% solution plus at home 5% minoxidil treatment. The primary endpoints will be to
assess the change from baseline in investigator and subject Hair Growth Assessments (HGA),
Hair Growth Index (HGI) and the Hair Growth Satisfaction Scale (HGSS) over 8-12 weeks in each
of the three groups. The secondary endpoints will be expert assessment of hair density from
baseline and evaluation of safety and adverse events, and pharmacokinetic (PK) data.
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.